Bronnen:
Siddiqui SH, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523-25.,GOLD. 2019 global strategy for prevention, diagnosis and management of COPD. 2019. Beschikbaar via https://goldcopd.org/gold-reports/. ,Kerkhof M, et al. Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017;50(1). doi: 10.1183/13993003.00761-2017.,Wedzicha JA, et al. Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients. OA5348. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.
Siddiqui SH, et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523-25.,GOLD. 2019 global strategy for prevention, diagnosis and management of COPD. 2019. Beschikbaar via https://goldcopd.org/gold-reports/. ,Kerkhof M, et al. Blood eosinophil count and exacerbation risk in patients with COPD. Eur Respir J. 2017;50(1). doi: 10.1183/13993003.00761-2017.,Wedzicha JA, et al. Blood eosinophil count and exacerbation history in COPD: pooled analysis of 24,103 patients. OA5348. ERS 2019, 28 sep.-2 okt. 2019, Madrid, Spanje.